文献速递烧伤

入院时乳酸白蛋白比值对危重重度烧伤患者28天死亡率的预测价值:一项回顾性队列研究

Usefulness of lactate albumin ratio at admission to predict 28-day mortality in critically ill severely burned patients: A retrospective cohort study.
PubMed 文献 · Burns · 2022-01-05

回顾性队列纳入2012年6月至2018年12月ICU收治的471例烧伤患者,52例(12.4%)于28天死亡。入院LAR>0.13独立关联28天死亡率(校正OR=3.98,95%CI 1.88-8.35),LAR的AUC为0.81,与SOFA及ABSI相仿;但LAR预测并不优于单独乳酸水平。

要点

  • 入院LAR>0.13与28天死亡率独立相关(校正OR=3.98,95%CI 1.88-8.35)。
  • LAR≥0.13组28天死亡率40.6% vs LAR<0.13组6.8%(HR 7.39,95%CI 4.28-12.76)。
  • LAR区分28天死亡的AUC 0.81(95%CI 0.74-0.88),与SOFA、ABSI相仿,但不优于单独乳酸。

核心结论

  • 入院时LAR是简便可靠的标志物,独立关联重度烧伤患者28天死亡率;但LAR预测并不优于单独乳酸水平。

研究设计与样本

  • 主要终点为28天死亡率;人群以男性为主(249例,59.1%)。

主要发现

  • 中位年龄、烧伤总面积、全层面积、ABSI及IGS2分别为52[34-68]、20[10-40]、8[1-23]、7[5-9]和25[15-40]。
  • 52例(12.4%)于入院后28天死亡。
  • 入院时28天存活者LAR低于非存活者(0.05[0.04,0.08] vs 0.12[0.07,0.26],p<0.001)。
  • LAR≥0.13组28天死亡率40.6% vs LAR<0.13组6.8%(p<0.001,HR 7.39,95%CI 4.28-12.76)。
  • 入院LAR区分28天死亡的AUC 0.81(95%CI 0.74-0.88),SOFA 0.80(95%CI 0.72-0.85),ABSI 0.85(95%CI 0.80-0.90)。

关键数值与推荐

  • 校正ABSI后,入院LAR>0.13独立关联28天死亡率(校正OR=3.98,95%CI 1.88-8.35)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Lactate albumin ratio (LAR) has been used as a prognostic marker associated with organ failure in critically ill septic patients. LAR and its association with outcomes has never been studied in burned patients. The aim of this study was to evaluate the ability of LAR to predict 28-day mortality. METHODS: A retrospective cohort study including all burn patients hospitalized in intensive care unit. The primary endpoint was the 28-day mortality. RESULTS: One thousand three hundred thirty four patients were screened, and 471 were included between June 2012 and December 2018. Briefly, the population study was mainly composed by men (249, 59.1%), the median age, TBSA burned, full thickness, ABSI and IGS2 were 52 [34-68], 20 [10-40], 8 [1-23], 7 [5-9] and 25 [15-40] respectively. Fifty-two patients (12.4%) died at day 28 after admission. At admission, the LAR level was lower in 28-day survivors compared non-survivors (0.05 [0.04, 0.08] vs 0.12 [0.07, 0.26], p < 0.001 respectively). In multivariate analysis accounting for ABSI, LAR levels at admission> 0.13 was independently associated with 28-day mortality (adjusted OR = 3.98 (IC95 1.88-8.35)). The ability of LAR at admission to discriminate 28-day mortality showed an AUC identical when compared to SOFA and ABSI scores (0.81 (IC95 0.74-0.88), 0.80 (IC95 0.72-0.85) and (0.85 (IC95 0.80-0.90), p < 0.05, respectively). Patients with LAR levels ≥ 0.13 at admission had higher 28-day mortality (40.6% vs 6.8%, p < 0.001, HR 7.39 (IC95 4.28-12.76)). CONCLUSION: At admission, LAR is an easy and reliable marker independently associated to 28-day mortality in patients with severe burn injury, but prediction by LAR does not perform better than lactate level alone.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Dudoignon E, Quennesson T, De Tymowski C, et al. Usefulness of lactate albumin ratio at admission to predict 28-day mortality in critically ill severely burned patients: A retrospective cohort study. Burns. 2022. PMID: 35012801. doi:10.1016/j.burns.2022.01.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。